HyperSpectral

Alexandria, United States Founded: 2020 • Age: 6 yrs
AI-powered real-time detection platform for pathogens
Annual revenue - Latest available
Total funding $34.3M 4 rounds
Employees - Tracked headcount
Investors 5 Known backers
Products 1 Services tracked
Competitors 7 Brand Intelligence

About HyperSpectral

HyperSpectral is a company based in Alexandria (United States) founded in 2020. HyperSpectral has raised $34.33 million across 4 funding rounds from investors including Kibo Ventures, Correlation Ventures and GC&H Investments. HyperSpectral offers products and services including SpecAI™. HyperSpectral operates in a competitive market with competitors including Nicoya Life, Novolyze, Specright, Redzone and Living Optics, among others.

  • Headquarter Alexandria, United States
  • Sectors
    Consumer
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Consumer → Food, Beverage & Nutrition
Technology → Quantum & Emerging Technologies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $34.33 M (USD)

    in 4 rounds

  • Latest Funding Round
    $7 M (USD), Series A

    Oct 07, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of HyperSpectral

HyperSpectral offers a comprehensive portfolio of products and services, including SpecAI™.

Primary

AI platform for real-time spectral data analysis and threat detection

Funding Insights of HyperSpectral

HyperSpectral has successfully raised a total of $34.33M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $7 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series A — $7.0M
  • First Round

    (03 May 2024)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2025 Amount Series A - HyperSpectral Valuation RRE Ventures , Kibo Ventures
Aug, 2025 Amount Series A - HyperSpectral Valuation

investors

Jun, 2024 Amount Series A - HyperSpectral Valuation Kibo Ventures , RRE Ventures

Investors in HyperSpectral

HyperSpectral has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Kibo Ventures, Correlation Ventures and GC&H Investments.

All
Venture Fund
Investor Description Founded Year Domain Location
Technology sectors are invested in by this venture capital firm.
Founded Year Domain Location
Venture capital firm focused on aerospace, biopharma, consumer, and multiple sectors
Founded Year Domain Location
Early-stage startups are funded through venture capital by GC&H Investments.
Founded Year Domain Location

Investments & Acquisitions by HyperSpectral

Investments

Financial Statements - HyperSpectral

Hyperspectral Comparisons

+
Add Comparison
Available on Premium

Competitors of HyperSpectral

HyperSpectral operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nicoya Life, Novolyze, Specright, Redzone and Living Optics, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Hyperspectral optical microscopes for surface analysis are provided.
domain founded_year HQ Location
Product safety management software for food businesses is provided.
domain founded_year HQ Location
Cloud-based ERP and PLM solutions for packaging specifications are developed.
domain founded_year HQ Location
Cloud-based digital production system for food and CPG manufacturers
domain founded_year HQ Location
Developers of a hyperspectral imager to capture images beyond the visible spectrum

Latest news on Hyperspectral

Frequently Asked Questions about HyperSpectral

HyperSpectral was founded in 2020 and raised its 1st funding round 4 years after it was founded.

HyperSpectral is headquartered in Alexandria, United States.

HyperSpectral is a funded company, having raised a total of $34.33M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8.5M, raised on May 03, 2024.

AI-powered real-time detection platform for pathogens. The platform leverages rich spectral data to provide a scalable, screen-first system for the real-time detection of a wide range of targets, including bacteria, viruses, gluten, methane, CO2, mold, contaminants, toxins, allergens, and VOCs.

HyperSpectral's top competitors include Specright, Living Optics and Nicoya Life.

HyperSpectral offers SpecAI™.

HyperSpectral has 5 investors. Key investors include Kibo Ventures, Correlation Ventures, GC&H Investments, RRE Ventures, and Avalanche Thinking.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available